(UroToday.com) The American Urological Association's 2025 Annual Meeting, in Las Vegas, Nevada, was host to the Plenary Session on Saturday. Dr. Samir Taneja gave the State-of-the-Art Lecture titled: ...

Dr Ahmed, who has amassed over 1.3 million followers on the video-sharing app, explained that Hoy initially presented with ...

Prostate cancer has distinct genetic properties in different groups of men that could be targeted to improve patient outcomes, new research suggests.

In Anchorage, Providence Alaska Medical Center has become the first facility in the state to offer an innovative treatment ...

"Prostate cancer is a worldwide problem. It is the most common cancer in men, with clear racial disparities,” said researcher ...

New AI Technology Will Improve Prostate Biopsy Accuracy and Procedure Workflow ®MRI-fusion guidance system with the Bot Image ...

The associate medical director of University Hospitals of Northamptonshire (UHN), Chandran Tanabalan, said: "Focal therapy ...

A biomarker, PROSTOX, predicted late genitourinary toxicity accurately in patients with prostate cancer, yielding an area under the curve of 0.76.

Northampton General Hospital is set to become one of the best equipped NHS hospitals for prostate cancer in the country with the launch of a pioneering new treatment.

Nearly all men with a polygenic risk score in the 90th percentile or above had a 10-year absolute risk for prostate cancer exceeding 3.8%. A polygenic risk score (PRS) identifies more patients with ...